Get Real Time Here
| Open1.510 | Close1.530 |
| Vol / Avg.280.136K / 1.062M | Mkt Cap68.132M |
| Day Range1.500 - 1.550 | 52 Wk Range0.560 - 1.930 |
Avrobio Stock (NASDAQ:AVRO), Quotes and News Summary
Avrobio Stock (NASDAQ: AVRO) stock price, news, charts, stock research, profile.
| Open1.510 | Close1.530 |
| Vol / Avg.280.136K / 1.062M | Mkt Cap68.132M |
| Day Range1.500 - 1.550 | 52 Wk Range0.560 - 1.930 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | 1.520 | 1.5900 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-13 | Wells Fargo | Yanan Zhu | Maintains | OverweightOverweight | Lowers | 2.50 | 2.00 |
| 2023-07-12 | Wedbush | David Nierengarten | Downgrades | OutperformNeutral | Announces | - | 2.00 |
| 2023-03-24 | Mizuho | Uy Ear | Maintains | Buy | Lowers | 6.00 | 5.00 |
| 2023-03-24 | Needham | Gil Blum | Reiterates | Buy | Maintains | - | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AVRO | Avrobio | 0.66% | 68.1M |
| FGEN | FibroGen | 6.98% | 82.6M |
| ELTX | Elicio Therapeutics | 0.51% | 65.8M |
| CLGN | CollPlant Biotechnologies | -0.98% | 67.7M |
| ACET | Adicet Bio | -4.11% | 60.3M |
How do I buy Avrobio (AVRO) stock?
You can purchase shares of Avrobio (NASDAQ: AVRO) through any online brokerage.
Who are Avrobio's (AVRO) competitors?
Other companies in Avrobio’s space includes: FibroGen (NASDAQ:FGEN), Elicio Therapeutics (NASDAQ:ELTX), CollPlant Biotechnologies (NASDAQ:CLGN), Adicet Bio (NASDAQ:ACET) and Evelo Biosciences (NASDAQ:EVLO).
What is the target price for Avrobio (AVRO) stock?
The latest price target for Avrobio (NASDAQ: AVRO) was reported by Wells Fargo on Thursday, July 13, 2023. The analyst firm set a price target for 2.00 expecting AVRO to rise to within 12 months (a possible 30.72% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Avrobio (AVRO)?
The stock price for Avrobio (NASDAQ: AVRO) is $1.53 last updated September 25, 2023 at 8:00 PM UTC.
Does Avrobio (AVRO) pay a dividend?
There is no dividend information for Avrobio.
When is Avrobio (NASDAQ:AVRO) reporting earnings?
Avrobio’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Avrobio (AVRO) going to split?
There is no upcoming split for Avrobio.
What sector and industry does Avrobio (AVRO) operate in?
Avrobio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Avrobio Stock (NASDAQ:AVRO), Quotes and News Summary
Avrobio Stock (NASDAQ: AVRO) stock price, news, charts, stock research, profile.
| Open1.510 | Close1.530 |
| Vol / Avg.280.136K / 1.062M | Mkt Cap68.132M |
| Day Range1.500 - 1.550 | 52 Wk Range0.560 - 1.930 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | 1.520 | 1.5900 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-13 | Wells Fargo | Yanan Zhu | Maintains | OverweightOverweight | Lowers | 2.50 | 2.00 |
| 2023-07-12 | Wedbush | David Nierengarten | Downgrades | OutperformNeutral | Announces | - | 2.00 |
| 2023-03-24 | Mizuho | Uy Ear | Maintains | Buy | Lowers | 6.00 | 5.00 |
| 2023-03-24 | Needham | Gil Blum | Reiterates | Buy | Maintains | - | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AVRO | Avrobio | 0.66% | 68.1M |
| FGEN | FibroGen | 6.98% | 82.6M |
| ELTX | Elicio Therapeutics | 0.51% | 65.8M |
| CLGN | CollPlant Biotechnologies | -0.98% | 67.7M |
| ACET | Adicet Bio | -4.11% | 60.3M |
How do I buy Avrobio (AVRO) stock?
You can purchase shares of Avrobio (NASDAQ: AVRO) through any online brokerage.
Who are Avrobio's (AVRO) competitors?
Other companies in Avrobio’s space includes: FibroGen (NASDAQ:FGEN), Elicio Therapeutics (NASDAQ:ELTX), CollPlant Biotechnologies (NASDAQ:CLGN), Adicet Bio (NASDAQ:ACET) and Evelo Biosciences (NASDAQ:EVLO).
What is the target price for Avrobio (AVRO) stock?
The latest price target for Avrobio (NASDAQ: AVRO) was reported by Wells Fargo on Thursday, July 13, 2023. The analyst firm set a price target for 2.00 expecting AVRO to rise to within 12 months (a possible 30.72% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Avrobio (AVRO)?
The stock price for Avrobio (NASDAQ: AVRO) is $1.53 last updated September 25, 2023 at 8:00 PM UTC.
Does Avrobio (AVRO) pay a dividend?
There is no dividend information for Avrobio.
When is Avrobio (NASDAQ:AVRO) reporting earnings?
Avrobio’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Avrobio (AVRO) going to split?
There is no upcoming split for Avrobio.
What sector and industry does Avrobio (AVRO) operate in?
Avrobio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Avrobio Stock (NASDAQ:AVRO), Quotes and News Summary
Avrobio Stock (NASDAQ: AVRO) stock price, news, charts, stock research, profile.
| Open1.510 | Close1.530 |
| Vol / Avg.280.136K / 1.062M | Mkt Cap68.132M |
| Day Range1.500 - 1.550 | 52 Wk Range0.560 - 1.930 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | 1.520 | 1.5900 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-13 | Wells Fargo | Yanan Zhu | Maintains | OverweightOverweight | Lowers | 2.50 | 2.00 |
| 2023-07-12 | Wedbush | David Nierengarten | Downgrades | OutperformNeutral | Announces | - | 2.00 |
| 2023-03-24 | Mizuho | Uy Ear | Maintains | Buy | Lowers | 6.00 | 5.00 |
| 2023-03-24 | Needham | Gil Blum | Reiterates | Buy | Maintains | - | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AVRO | Avrobio | 0.66% | 68.1M |
| FGEN | FibroGen | 6.98% | 82.6M |
| ELTX | Elicio Therapeutics | 0.51% | 65.8M |
| CLGN | CollPlant Biotechnologies | -0.98% | 67.7M |
| ACET | Adicet Bio | -4.11% | 60.3M |
How do I buy Avrobio (AVRO) stock?
You can purchase shares of Avrobio (NASDAQ: AVRO) through any online brokerage.
Who are Avrobio's (AVRO) competitors?
Other companies in Avrobio’s space includes: FibroGen (NASDAQ:FGEN), Elicio Therapeutics (NASDAQ:ELTX), CollPlant Biotechnologies (NASDAQ:CLGN), Adicet Bio (NASDAQ:ACET) and Evelo Biosciences (NASDAQ:EVLO).
What is the target price for Avrobio (AVRO) stock?
The latest price target for Avrobio (NASDAQ: AVRO) was reported by Wells Fargo on Thursday, July 13, 2023. The analyst firm set a price target for 2.00 expecting AVRO to rise to within 12 months (a possible 30.72% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Avrobio (AVRO)?
The stock price for Avrobio (NASDAQ: AVRO) is $1.53 last updated September 25, 2023 at 8:00 PM UTC.
Does Avrobio (AVRO) pay a dividend?
There is no dividend information for Avrobio.
When is Avrobio (NASDAQ:AVRO) reporting earnings?
Avrobio’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Avrobio (AVRO) going to split?
There is no upcoming split for Avrobio.
What sector and industry does Avrobio (AVRO) operate in?
Avrobio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Avrobio Stock (NASDAQ:AVRO), Quotes and News Summary
Avrobio Stock (NASDAQ: AVRO) stock price, news, charts, stock research, profile.
| Open1.510 | Close1.530 |
| Vol / Avg.280.136K / 1.062M | Mkt Cap68.132M |
| Day Range1.500 - 1.550 | 52 Wk Range0.560 - 1.930 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | 1.520 | 1.5900 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-13 | Wells Fargo | Yanan Zhu | Maintains | OverweightOverweight | Lowers | 2.50 | 2.00 |
| 2023-07-12 | Wedbush | David Nierengarten | Downgrades | OutperformNeutral | Announces | - | 2.00 |
| 2023-03-24 | Mizuho | Uy Ear | Maintains | Buy | Lowers | 6.00 | 5.00 |
| 2023-03-24 | Needham | Gil Blum | Reiterates | Buy | Maintains | - | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AVRO | Avrobio | 0.66% | 68.1M |
| FGEN | FibroGen | 6.98% | 82.6M |
| ELTX | Elicio Therapeutics | 0.51% | 65.8M |
| CLGN | CollPlant Biotechnologies | -0.98% | 67.7M |
| ACET | Adicet Bio | -4.11% | 60.3M |
How do I buy Avrobio (AVRO) stock?
You can purchase shares of Avrobio (NASDAQ: AVRO) through any online brokerage.
Who are Avrobio's (AVRO) competitors?
Other companies in Avrobio’s space includes: FibroGen (NASDAQ:FGEN), Elicio Therapeutics (NASDAQ:ELTX), CollPlant Biotechnologies (NASDAQ:CLGN), Adicet Bio (NASDAQ:ACET) and Evelo Biosciences (NASDAQ:EVLO).
What is the target price for Avrobio (AVRO) stock?
The latest price target for Avrobio (NASDAQ: AVRO) was reported by Wells Fargo on Thursday, July 13, 2023. The analyst firm set a price target for 2.00 expecting AVRO to rise to within 12 months (a possible 30.72% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Avrobio (AVRO)?
The stock price for Avrobio (NASDAQ: AVRO) is $1.53 last updated September 25, 2023 at 8:00 PM UTC.
Does Avrobio (AVRO) pay a dividend?
There is no dividend information for Avrobio.
When is Avrobio (NASDAQ:AVRO) reporting earnings?
Avrobio’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Avrobio (AVRO) going to split?
There is no upcoming split for Avrobio.
What sector and industry does Avrobio (AVRO) operate in?
Avrobio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Avrobio Stock (NASDAQ:AVRO), Quotes and News Summary
Avrobio Stock (NASDAQ: AVRO) stock price, news, charts, stock research, profile.
| Open1.510 | Close1.530 |
| Vol / Avg.280.136K / 1.062M | Mkt Cap68.132M |
| Day Range1.500 - 1.550 | 52 Wk Range0.560 - 1.930 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | 1.520 | 1.5900 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-13 | Wells Fargo | Yanan Zhu | Maintains | OverweightOverweight | Lowers | 2.50 | 2.00 |
| 2023-07-12 | Wedbush | David Nierengarten | Downgrades | OutperformNeutral | Announces | - | 2.00 |
| 2023-03-24 | Mizuho | Uy Ear | Maintains | Buy | Lowers | 6.00 | 5.00 |
| 2023-03-24 | Needham | Gil Blum | Reiterates | Buy | Maintains | - | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AVRO | Avrobio | 0.66% | 68.1M |
| FGEN | FibroGen | 6.98% | 82.6M |
| ELTX | Elicio Therapeutics | 0.51% | 65.8M |
| CLGN | CollPlant Biotechnologies | -0.98% | 67.7M |
| ACET | Adicet Bio | -4.11% | 60.3M |
How do I buy Avrobio (AVRO) stock?
You can purchase shares of Avrobio (NASDAQ: AVRO) through any online brokerage.
Who are Avrobio's (AVRO) competitors?
Other companies in Avrobio’s space includes: FibroGen (NASDAQ:FGEN), Elicio Therapeutics (NASDAQ:ELTX), CollPlant Biotechnologies (NASDAQ:CLGN), Adicet Bio (NASDAQ:ACET) and Evelo Biosciences (NASDAQ:EVLO).
What is the target price for Avrobio (AVRO) stock?
The latest price target for Avrobio (NASDAQ: AVRO) was reported by Wells Fargo on Thursday, July 13, 2023. The analyst firm set a price target for 2.00 expecting AVRO to rise to within 12 months (a possible 30.72% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Avrobio (AVRO)?
The stock price for Avrobio (NASDAQ: AVRO) is $1.53 last updated September 25, 2023 at 8:00 PM UTC.
Does Avrobio (AVRO) pay a dividend?
There is no dividend information for Avrobio.
When is Avrobio (NASDAQ:AVRO) reporting earnings?
Avrobio’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Avrobio (AVRO) going to split?
There is no upcoming split for Avrobio.
What sector and industry does Avrobio (AVRO) operate in?
Avrobio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Avrobio Stock (NASDAQ:AVRO), Quotes and News Summary
Avrobio Stock (NASDAQ: AVRO) stock price, news, charts, stock research, profile.
| Open1.510 | Close1.530 |
| Vol / Avg.280.136K / 1.062M | Mkt Cap68.132M |
| Day Range1.500 - 1.550 | 52 Wk Range0.560 - 1.930 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | 1.520 | 1.5900 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-13 | Wells Fargo | Yanan Zhu | Maintains | OverweightOverweight | Lowers | 2.50 | 2.00 |
| 2023-07-12 | Wedbush | David Nierengarten | Downgrades | OutperformNeutral | Announces | - | 2.00 |
| 2023-03-24 | Mizuho | Uy Ear | Maintains | Buy | Lowers | 6.00 | 5.00 |
| 2023-03-24 | Needham | Gil Blum | Reiterates | Buy | Maintains | - | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AVRO | Avrobio | 0.66% | 68.1M |
| FGEN | FibroGen | 6.98% | 82.6M |
| ELTX | Elicio Therapeutics | 0.51% | 65.8M |
| CLGN | CollPlant Biotechnologies | -0.98% | 67.7M |
| ACET | Adicet Bio | -4.11% | 60.3M |
How do I buy Avrobio (AVRO) stock?
You can purchase shares of Avrobio (NASDAQ: AVRO) through any online brokerage.
Who are Avrobio's (AVRO) competitors?
Other companies in Avrobio’s space includes: FibroGen (NASDAQ:FGEN), Elicio Therapeutics (NASDAQ:ELTX), CollPlant Biotechnologies (NASDAQ:CLGN), Adicet Bio (NASDAQ:ACET) and Evelo Biosciences (NASDAQ:EVLO).
What is the target price for Avrobio (AVRO) stock?
The latest price target for Avrobio (NASDAQ: AVRO) was reported by Wells Fargo on Thursday, July 13, 2023. The analyst firm set a price target for 2.00 expecting AVRO to rise to within 12 months (a possible 30.72% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Avrobio (AVRO)?
The stock price for Avrobio (NASDAQ: AVRO) is $1.53 last updated September 25, 2023 at 8:00 PM UTC.
Does Avrobio (AVRO) pay a dividend?
There is no dividend information for Avrobio.
When is Avrobio (NASDAQ:AVRO) reporting earnings?
Avrobio’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Avrobio (AVRO) going to split?
There is no upcoming split for Avrobio.
What sector and industry does Avrobio (AVRO) operate in?
Avrobio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Avrobio Stock (NASDAQ:AVRO), Quotes and News Summary
Avrobio Stock (NASDAQ: AVRO) stock price, news, charts, stock research, profile.
| Open1.510 | Close1.530 |
| Vol / Avg.280.136K / 1.062M | Mkt Cap68.132M |
| Day Range1.500 - 1.550 | 52 Wk Range0.560 - 1.930 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | 1.520 | 1.5900 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-13 | Wells Fargo | Yanan Zhu | Maintains | OverweightOverweight | Lowers | 2.50 | 2.00 |
| 2023-07-12 | Wedbush | David Nierengarten | Downgrades | OutperformNeutral | Announces | - | 2.00 |
| 2023-03-24 | Mizuho | Uy Ear | Maintains | Buy | Lowers | 6.00 | 5.00 |
| 2023-03-24 | Needham | Gil Blum | Reiterates | Buy | Maintains | - | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AVRO | Avrobio | 0.66% | 68.1M |
| FGEN | FibroGen | 6.98% | 82.6M |
| ELTX | Elicio Therapeutics | 0.51% | 65.8M |
| CLGN | CollPlant Biotechnologies | -0.98% | 67.7M |
| ACET | Adicet Bio | -4.11% | 60.3M |
How do I buy Avrobio (AVRO) stock?
You can purchase shares of Avrobio (NASDAQ: AVRO) through any online brokerage.
Who are Avrobio's (AVRO) competitors?
Other companies in Avrobio’s space includes: FibroGen (NASDAQ:FGEN), Elicio Therapeutics (NASDAQ:ELTX), CollPlant Biotechnologies (NASDAQ:CLGN), Adicet Bio (NASDAQ:ACET) and Evelo Biosciences (NASDAQ:EVLO).
What is the target price for Avrobio (AVRO) stock?
The latest price target for Avrobio (NASDAQ: AVRO) was reported by Wells Fargo on Thursday, July 13, 2023. The analyst firm set a price target for 2.00 expecting AVRO to rise to within 12 months (a possible 30.72% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Avrobio (AVRO)?
The stock price for Avrobio (NASDAQ: AVRO) is $1.53 last updated September 25, 2023 at 8:00 PM UTC.
Does Avrobio (AVRO) pay a dividend?
There is no dividend information for Avrobio.
When is Avrobio (NASDAQ:AVRO) reporting earnings?
Avrobio’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Avrobio (AVRO) going to split?
There is no upcoming split for Avrobio.
What sector and industry does Avrobio (AVRO) operate in?
Avrobio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Avrobio Stock (NASDAQ:AVRO), Quotes and News Summary
Avrobio Stock (NASDAQ: AVRO) stock price, news, charts, stock research, profile.
| Open1.510 | Close1.530 |
| Vol / Avg.280.136K / 1.062M | Mkt Cap68.132M |
| Day Range1.500 - 1.550 | 52 Wk Range0.560 - 1.930 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | 1.520 | 1.5900 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-13 | Wells Fargo | Yanan Zhu | Maintains | OverweightOverweight | Lowers | 2.50 | 2.00 |
| 2023-07-12 | Wedbush | David Nierengarten | Downgrades | OutperformNeutral | Announces | - | 2.00 |
| 2023-03-24 | Mizuho | Uy Ear | Maintains | Buy | Lowers | 6.00 | 5.00 |
| 2023-03-24 | Needham | Gil Blum | Reiterates | Buy | Maintains | - | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AVRO | Avrobio | 0.66% | 68.1M |
| FGEN | FibroGen | 6.98% | 82.6M |
| ELTX | Elicio Therapeutics | 0.51% | 65.8M |
| CLGN | CollPlant Biotechnologies | -0.98% | 67.7M |
| ACET | Adicet Bio | -4.11% | 60.3M |
How do I buy Avrobio (AVRO) stock?
You can purchase shares of Avrobio (NASDAQ: AVRO) through any online brokerage.
Who are Avrobio's (AVRO) competitors?
Other companies in Avrobio’s space includes: FibroGen (NASDAQ:FGEN), Elicio Therapeutics (NASDAQ:ELTX), CollPlant Biotechnologies (NASDAQ:CLGN), Adicet Bio (NASDAQ:ACET) and Evelo Biosciences (NASDAQ:EVLO).
What is the target price for Avrobio (AVRO) stock?
The latest price target for Avrobio (NASDAQ: AVRO) was reported by Wells Fargo on Thursday, July 13, 2023. The analyst firm set a price target for 2.00 expecting AVRO to rise to within 12 months (a possible 30.72% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Avrobio (AVRO)?
The stock price for Avrobio (NASDAQ: AVRO) is $1.53 last updated September 25, 2023 at 8:00 PM UTC.
Does Avrobio (AVRO) pay a dividend?
There is no dividend information for Avrobio.
When is Avrobio (NASDAQ:AVRO) reporting earnings?
Avrobio’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Avrobio (AVRO) going to split?
There is no upcoming split for Avrobio.
What sector and industry does Avrobio (AVRO) operate in?
Avrobio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Avrobio Stock (NASDAQ:AVRO), Quotes and News Summary
Avrobio Stock (NASDAQ: AVRO) stock price, news, charts, stock research, profile.
| Open1.510 | Close1.530 |
| Vol / Avg.280.136K / 1.062M | Mkt Cap68.132M |
| Day Range1.500 - 1.550 | 52 Wk Range0.560 - 1.930 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | 1.520 | 1.5900 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-13 | Wells Fargo | Yanan Zhu | Maintains | OverweightOverweight | Lowers | 2.50 | 2.00 |
| 2023-07-12 | Wedbush | David Nierengarten | Downgrades | OutperformNeutral | Announces | - | 2.00 |
| 2023-03-24 | Mizuho | Uy Ear | Maintains | Buy | Lowers | 6.00 | 5.00 |
| 2023-03-24 | Needham | Gil Blum | Reiterates | Buy | Maintains | - | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AVRO | Avrobio | 0.66% | 68.1M |
| FGEN | FibroGen | 6.98% | 82.6M |
| ELTX | Elicio Therapeutics | 0.51% | 65.8M |
| CLGN | CollPlant Biotechnologies | -0.98% | 67.7M |
| ACET | Adicet Bio | -4.11% | 60.3M |
How do I buy Avrobio (AVRO) stock?
You can purchase shares of Avrobio (NASDAQ: AVRO) through any online brokerage.
Who are Avrobio's (AVRO) competitors?
Other companies in Avrobio’s space includes: FibroGen (NASDAQ:FGEN), Elicio Therapeutics (NASDAQ:ELTX), CollPlant Biotechnologies (NASDAQ:CLGN), Adicet Bio (NASDAQ:ACET) and Evelo Biosciences (NASDAQ:EVLO).
What is the target price for Avrobio (AVRO) stock?
The latest price target for Avrobio (NASDAQ: AVRO) was reported by Wells Fargo on Thursday, July 13, 2023. The analyst firm set a price target for 2.00 expecting AVRO to rise to within 12 months (a possible 30.72% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Avrobio (AVRO)?
The stock price for Avrobio (NASDAQ: AVRO) is $1.53 last updated September 25, 2023 at 8:00 PM UTC.
Does Avrobio (AVRO) pay a dividend?
There is no dividend information for Avrobio.
When is Avrobio (NASDAQ:AVRO) reporting earnings?
Avrobio’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Avrobio (AVRO) going to split?
There is no upcoming split for Avrobio.
What sector and industry does Avrobio (AVRO) operate in?
Avrobio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.